Dogwood Therapeutics
DWTX
10 hedge funds and large institutions have $208K invested in Dogwood Therapeutics in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 4 closing their positions.
2.03% less ownership
Funds ownership: 4.29% → 2.26% (-2%)
23% less funds holding
Funds holding: 13 → 10 (-3)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
49% less capital invested
Capital invested by funds: $410K → $208K (-$202K)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$81.5K |
| 2 |
Raymond James Financial
St Petersburg,
Florida
|
+$116 |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$34 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$149K |
| 2 |
FIA
FNY Investment Advisers
New York
|
-$62K |
| 3 |
HF
HRT Financial
New York
|
-$56K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$7.67K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.25K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $83.2K | +$81.5K | +16,850 | +2,808% |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $61.9K | -$7.67K | -1,586 | -11% |
|
3
Vanguard Group
Malvern,
Pennsylvania
| $56.9K | – | – | – |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $3.78K | -$1.25K | -258 | -25% |
|
|
SS
5
SBI Securities
Tokyo,
Japan
| $730 | -$169 | -35 | -19% |
|
|
AWM
6
Activest Wealth Management
Aventure,
Florida
| $572 | – | – | – |
|
7
BlackRock
New York
| $143 | – | – | – |
|
|
8
Raymond James Financial
St Petersburg,
Florida
| $114 | +$116 | +24 | New |
|
|
9
Bank of America
Charlotte,
North Carolina
| $81 | +$34 | +7 | +70% |
|
10
Group One Trading
Chicago,
Illinois
| $43 | – | – | – |
|
|
11
UBS Group
Zurich,
Switzerland
| – | -$149K | -29,818 | Closed |
|
|
FIA
12
FNY Investment Advisers
New York
| – | -$62K | -12,500 | Closed |
|
|
HF
13
HRT Financial
New York
| – | -$56K | -11,228 | Closed |
|
14
Fidelity Investments
Boston,
Massachusetts
| – | -$1.13K | -225 | Closed |
|
DWTX Hedge Fund Activity: Q2 2025 in Review
10 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Dogwood Therapeutics (DWTX) for Q2 2025, worth a combined $208K — down 49% from $410K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of DWTX and 1 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 2 added.
The largest buyer was Morgan Stanley, adding an estimated $81.5K. The largest seller was UBS Group, exiting entirely with an estimated $149K sold.
- 10 institutional investors held Dogwood Therapeutics (DWTX) as of Q2 2025, down from 13 in Q1 2025.
- Funds reported $208K of Dogwood Therapeutics stock for Q2 2025, down 49% quarter-over-quarter.
- 1 fund opened new Dogwood Therapeutics positions in Q2 2025 and 4 closed out, a net change of -3 holders.
- The largest Dogwood Therapeutics buyer in Q2 2025 was Morgan Stanley, an estimated $81.5K added.
- The largest Dogwood Therapeutics seller in Q2 2025 was UBS Group, an estimated $149K sold.
Based on aggregated 13F filings for Q2 2025.